Day: February 9, 2022

SOUTH ORANGE, NJ, Feb. 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter financial results on Wednesday, February 23, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be added into the Nephros conference call. A replay of the call can be accessed until March 2, 2022 at 1 (877) 344-7529 or 1 (412) 317-0088 for international callers and entering replay access code: 8949087.  An audio archive of the call will be available shortly after the call...

SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that company management will participate in a fireside chat at the annual SVB Leerink Global Healthcare Conference, which is being held in a virtual format February 14-18, 2022. Details of the presentation are as follows:Date: Wednesday, February 16, 2022Time: 1:00 p.m. Eastern TimeWebcast Link: https://wsw.com/webcast/svbleerink67/crnx/2679350   In addition, the live and archived presentation will be accessible on the Events & Presentations page in the Investors section on the Company’s website. About Crinetics PharmaceuticalsCrinetics...

BRAINTREE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — Altra Industrial Motion Corp. (Nasdaq: AIMC) (“Altra” or the “Company”), a leading global manufacturer and supplier of motion control, power transmission and automation products, today announced that it has entered into an agreement to sell its Jacobs Vehicle Systems (JVS) business to Cummins Inc. for $325 million. The business generated approximately $193 million in revenue in 2021. “Today’s announcement is fully aligned with our strategy to focus Altra’s portfolio on highly engineered products in the motion control and power transmission markets,” said Carl Christenson, Altra’s Chairman and Chief Executive Officer. “We believe that the sale of Jacobs Vehicle Systems to Cummins, a well-established leader in the heavy-duty trucking industry, will give the JVS business an opportunity...

DURHAM, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Chief Executive Officer, and Dale Sander, Chief Financial Officer, will participate in a virtual fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 15, 2022, at 9 a.m. EST. The webcast will be available for replay for at least 30 days following the presentation at https://humacyte.gcs-web.com/news-events/events-and-presentations. About HumacyteHumacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the...

DANBURY, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in decarbonizing power and producing hydrogen with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy — today announced that it will host a virtual investor day on Wednesday, March 16, 2022 at 10:00 a.m. Eastern Time. A sample of topics to be discussed include the Company’s long-term growth opportunities and strategy, business execution and financial outlook, capital allocation priorities, and plans to drive long-term shareholder value. Presenting from FuelCell Energy will be: Jason Few, President and Chief Executive OfficerMichael Lisowski, EVP and Chief Operating OfficerTony Leo, EVP and Chief Technology OfficerMichael Bishop, EVP and Chief Financial...

CLEARFIELD, Pa., Feb. 09, 2022 (GLOBE NEWSWIRE) — Together, Peter F. Smith, Chairman of the Board of Directors for CNB Bank and CNB Financial Corporation, and Joseph B. Bower, Jr., CEO of CNB Bank and President and CEO of CNB Financial Corporation, announced Mr. Bower’s intention to retire from these positions, effective July 1, 2022 and December 31, 2022, respectively. For the remainder of the year, Mr. Bower will work closely with his successor, Michael Peduzzi, President and Chief Operating Officer of CNB Bank, who will succeed Mr. Bower as President and CEO of CNB Financial Corporation, effective December 31, 2022, and CEO of CNB Bank, effective July 1, 2022. The announcement of Mr. Bower’s retirement honors his twenty-five year career with the Company and remarkable leadership to CNB Bank and CNB Financial Corporation. He...

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (the “Company” or “WPD”) (CSE: WBIO) (FSE: 8SV1) announces that the Company’s board of directors (the “Board”) has approved a plan to restructure (the “Restructuring”) the outstanding capitalization of the Company’s wholly owned Polish subsidiary WPD Pharmaceuticals sp. z.o.o. (“WPD Poland”). Due to the occurrence of negative shareholders’ equity in WPD Poland, under Polish corporate law, WPD Poland is obligated to convene an extraordinary general meeting of its shareholders to vote on the implementation of a recovery plan or file a bankruptcy proceeding. As the Company is sole shareholder of WPD, the Board has approved a recovery plan of WPD Poland, being the Restructuring. Under the Restructuring, the first step is that the outstanding share...